Screener
Bio-Rad Laboratories BIO Pre-Tax Income
Pre-Tax Income at other companies
Other financials
Where this comes from
Reported directly by Bio-Rad Laboratories in its filing.
Tagged under the XBRL concept us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest.
The source filing: Bio-Rad Laboratories’s 10-Q, filed April 30, 2026.
- Filed
- Apr 30, 2026, 4:19 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0000012208-26-000035
| Line item | Three Months Ended / March 31, 2026 | Three Months Ended / March 31, 2025 |
|---|---|---|
| Foreign currency exchange gains, net | (2.4) | (2.7) |
| (Gains) losses from change in fair market value of equity securities and loan receivable | 738.2 | (31.8) |
| Other income, net | (24.2) | (37.2) |
| Income (loss) before income taxes | (689.8) | 83.4 |
| (Provision for) benefit from income taxes | 162.7 | (19.4) |
| Net income (loss) | $(527.1) | $64.0 |
| Basic earnings (loss) per share: | ||
| Net income (loss) per basic share | $(19.55) | $2.29 |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Bio-Rad Laboratories's pre-tax income?
- Bio-Rad Laboratories (BIO) reported pre-tax income of -$689.8M in Q1 2026.
- How has Bio-Rad Laboratories's pre-tax income changed year-over-year?
- Bio-Rad Laboratories's pre-tax income decreased by 927.1% year-over-year, from $83.4M to -$689.8M.
- What does pre-tax income mean?
- Total income from all sources — operating income plus non-operating items like interest income, investment gains, and other income — before the provision for income taxes.
Ask your AI about Bio-Rad Laboratories's pre-tax income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude